What We Do


Accumol understands the challenges faced by clinical laboratories. We develop evolved molecular biology tools that are relevant, efficient, and in tune with the latest techniques. Yet, we take pride in designing very simple procedures, with no learning curve, ready to be implemented immediately in a controlled environment.

Evolved Tools
  • innovative molecular biology reagents
  • designed from the ground up for the needs of clinical laboratories
  • pre-mixed, pre-optimized reagent formulations
  • focus on quality and reliability
Simple Procedures
  • zero learning curve; ready to implement
  • just add your sample to PCR tube
  • works with existing equipment
  • use your current techniques
  • easy results analysis


Genomic Purity Detection Kits

Available for classical PCR and qPCR
  • Assess the purity of sorted T-cells, B-cells, or Myeloid cells directly in the genomic DNA sample
  • Save cells; stop performing flow cytometry
  • Use only 2 ng of DNA (less than 1,000 cells!)
  • Just add sample to pre-filled reaction tube or qPCR mix
  • Use the equipment already in your lab
  • Easy integration within existing workflow
  • Can be performed on frozen DNA, even years after cell sorting

New Products Coming Soon!

NK Purity Assessment Kit.


New Publication
December 2020
HLA, 2020, Early online version
A one‐step assay for sorted CD3+ cell purity and chimerism after hematopoietic stem cell transplantation.
Desoutter et al.

qPCR kits released!
April 25, 2017
The Non-T and Non-B Genomic Detection kits are now available for quantitative PCR (real-time PCR) instruments. In addition, we are pleased to introduce the brand new qPCR Non-Myeloid Genomic Detection kit, designed to assess the purity of Myeloid cell preparations directly at the DNA level.

New Publication
January 2015
British Journal of Haematology, 2015, 168, 26–37
Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): technical recommendations for the use of short tandem repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group.